Results 31 to 40 of about 22,933 (185)
Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
Journal of Market Access & Health Policy, 2017 Objective: To evaluate the cost-effectiveness of bedaquiline plus background drug regimens (BR) for multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) in Italy.
Luigi R. Codecasa +9 more
doaj +1 more source
International Journal of Infectious Diseases, 2018 Objectives: This study compared the yield of tuberculosis (TB) among contacts of multidrug-resistant tuberculosis (MDR-TB) index cases with that in drug-sensitive TB (DS-TB) index cases in a program setting.
Nebiyu Hiruy +9 more
doaj +1 more source
BMC Public Health, 2019 Background Multidrug-resistant tuberculosis (MDR-TB) is caused by bacteria that are resistant to the most effective anti-tuberculosis drug. The MDR-TB is an increasing global problem and the spread of MDR-TB has different recovery time for different ...
Yigzaw Alemu Limenih +1 more
doaj +1 more source
International Journal of Mycobacteriology, 2021 Background: Cases of tuberculosis (TB) and multidrug-resistant TB (MDR-TB) in South-east Asia including Indonesia are still high. The presence of mixed infections in TB cases has been reported. Several studies revealed the role of the human microbiome in
Nurul Wiqoyah +3 more
doaj +1 more source
Indian Journal of Respiratory Care, 2020 Introduction: Multidrug-resistant tuberculosis (MDR-TB) has created a significant health problem in most of the countries, and it is an obstacle to effective TB control.
Gauri Suhas Kulkarni +4 more
doaj +1 more source
Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study [PDF]
Epidemiology and Health, 2019 OBJECTIVES The emergence of multidrug-resistant tuberculosis (MDR-TB) is a major challenge for the global control of tuberculosis (TB). The aim of this study was to determine the risk factors associated with MDR-TB in Sudan.
Adel Hussein Elduma +6 more
doaj +1 more source
Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019
Emerging Infectious Diseases, 2022 Definitions of resistance in multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB) have been updated. Pre–XDR TB, defined as MDR TB with additional resistance to fluoroquinolones, and XDR TB, with additional ...
Yousra Kherabi +7 more
doaj +1 more source
International Journal of Infectious Diseases, 2023 Rifampicin-resistant tuberculosis (RR-TB) accounts for an expanding proportion of incident global TB cases and is a major barrier to global tuberculosis control. Conventional therapy for RR-TB is more toxic, less effective, and much more costly than drug-susceptible TB.
openaire +2 more sources
Risk for multidrug-resistant tuberculosis in patients treated with anti-tumor necrosis factor agents
Frontiers in Medicine, 2023 BackgroundThere are few studies on medical conditions associated with the development of drug-resistant TB.ObjectiveWe investigated the risk factors for the occurrence of multidrug-resistant (MDR) tuberculosis (TB) in patients with pulmonary TB.Materials
Jinkyeong Park +2 more
doaj +1 more source
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Advanced Materials, EarlyView.Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa +3 more
wiley +1 more source